Get started
Author

York Francis Zöllner

Observed names: Y Zoellner, Y Zöllner, Y. ZOELLNER, Y. Zoellner, Y. Zöllner, Y.F. Zöllner, YORK F. ZOELLNER, York F Zoellner, York F Zöllner, York F. Zöllner, York Francis Zoellner, York Zoellner, York ZÖLLNER, York Zöllner, Zöllner, York, Zöllner, York Francis
Institution: HAW Hamburg
Observed institutions: Universität Hamburg, Humboldt-Universität zu Berlin, MSH Medical School Hamburg – University of Applied Sciences and Medical University, Solvay (Germany), Abbott (Switzerland), Solvay (Netherlands), HAW Hamburg
OpenAlex ID: A5108833038
Vaccination: the cornerstone of an efficient healthcare system
2015 · Vanessa Rémy, York Zöllner, et al. · Journal of Market Access & Health Policy · 277
PDF
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries
2006 · James Ryan, York Zoellner, et al. · Vaccine · 182
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries
2014 · Marlene C. Hechtner, Thomas Vogt, et al. · Parkinsonism & Related Disorders · 164
The value of childhood combination vaccines: From beliefs to evidence
2015 · Khaled Maman, York Zöllner, et al. · Human Vaccines & Immunotherapeutics · 161
PDF
Pancreatic Enzyme Replacement Therapy in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis
2014 · Jan G. D’Haese, Güralp O. Ceyhan, et al. · Pancreas · 84
Estimating a preference-based index for a menopause specific health quality of life questionnaire
2005 · John E Brazier, Jennifer Roberts, et al. · Health and Quality of Life Outcomes · 55
PDF
Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements
2010 · Michael Willis, Ulf Persson, et al. · Applied Health Economics and Health Policy · 52
Comparison of NITAG policies and working processes in selected developed countries
2014 · G.W. Ricciardi, M. Toumi, et al. · Vaccine · 49
PDF
Waist–Hip Ratio More Appropriate Than Body Mass Index
2020 · Michael G. Haufs, York F. Zöllner · Deutsches Ärzteblatt international · 33
Drug related problems with Antiparkinsonian agents: consumer Internet reports versus published data
2007 · Sabrina Schröder, York Francis Zöllner, et al. · Pharmacoepidemiology and Drug Safety · 33
A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction
2006 · Mark Lamotte, Lieven Annemans, et al. · PharmacoEconomics · 33
Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply
2004 · Jeroen K Medema, York F Zoellner, et al. · Virus Research · 27
Multimorbidity in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results From a Longitudinal, Multicenter Data Linkage Study
2020 · Shifa H. Sarica, Peter J. Gallacher, et al. · Arthritis & Rheumatology · 22
PDF
Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis
2007 · Kavi J Littlewood, Wolfgang Greiner, et al. · BMC Nephrology · 22
PDF
Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model
2009 · Björn Schwander, Birgit Gradl, et al. · Value in Health · 19
A cost-effectiveness analysis of n-3 PUFA (Omacor®) treatment in post-MI patients
2006 · S. QUILICI, M. MARTIN, et al. · International Journal of Clinical Practice · 17
PDF
Budget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysis
2018 · Maria Gueltzow, Poroshat Khalilpour, et al. · Journal of Market Access & Health Policy · 16
Epidemiology and the Medical Burden of Diabetic Foot Ulcers Especially in Patients With Infection—A Population‐Based Analysis From Germany
2025 · Jürgen Wernecke, Marie Wernecke, et al. · International Wound Journal · 15
Long-term cost-effectiveness of matrix-associated chondrocyte implantation in the German health care system: a discrete event simulation
2022 · Tobias Vogelmann, Philip P. Roessler, et al. · Archives of Orthopaedic and Trauma Surgery · 15
PDF
Beyond the pill: The move towards value-added services in the pharmaceutical industry
2014 · Meike Wenzel, Nathalie Henne, et al. · Journal of Medical Marketing Device Diagnostic and Pharmaceutical Marketing · 13
Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®
2017 · A. Lewis, S. Torvinen, et al. · Respiratory Medicine · 12
PDF
Budget Impact Analysis of a Home-Based Nutrition Program for Adults at Risk for Malnutrition.
2020 · Suela Sulo, David Lanctin, et al. · PubMed Central · 11
The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systems
2023 · Marc Van Ranst, York Zöllner, et al. · Expert Review of Vaccines · 10
PDF
Transitioning to community-based mental health service delivery: opportunities for Ukraine
2020 · Eleanor Quirke, Orest Suvalo, et al. · Journal of Market Access & Health Policy · 10
Cost-effectiveness of a new ACI technique for the treatment of articular cartilage defects of the knee compared to regularly used ACI technique and microfracture
2023 · Martyn Snow, Vipul Mandalia, et al. · Journal of Medical Economics · 9
Works count: 55
Citation count: 1,387
H-index: 16
I10-index: 24
Year
Topic
Type